PHILIP RUBINFELD: Open Payments
NPI 1629074091 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$968 in 35 payments from 13 companies in 2025. Trend: 2023 $394 · 2024 $601 · 2025 $968
Food & beverage: $968
| Company | Payments | Amount |
|---|---|---|
| BIOTRONIK NRO, Inc. | 7 | $448 |
| Collegium Pharmaceutical, Inc. | 7 | $114 |
| ABBVIE INC. | 5 | $86 |
| Medtronic, Inc. | 2 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
| Boston Scientific Corporation | 2 | $42 |
| Abbott Laboratories | 2 | $36 |
| Nalu Medical, Inc. | 1 | $29 |
| Electronic Waveform Lab, Inc. | 2 | $23 |
| Foundation Fusion Solutions, LLC | 1 | $23 |
Products named: Prospera, XTAMPZA, UBRELVY, INCEPTIV, RELISTOR, ETERNA, Nalu Neurostimulation System, General - Pain Management.
Industry payments across NJ — which companies pay providers there.
